4 min read
Veranex Blog
Regulatory (2)
2 min read
New Proposal for Extended Transition Periods for IVDs: Can Manufacturers Slow Down Transition Efforts?
5 min read
Nanomaterials in Medical Devices: Biological Risks and Methodology for Biocompatibility Assessment
2 min read
Basics of Drug Safety: Importance of Case Processing in Pharmacovigilance (PV)
2 min read
The New Normal for Market Access in China: Volume Based Procurement
2 min read
FDA Releases Final Guidance on Oncology Therapeutic Class Labeling of Companion Diagnostics
1 min read



